Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
covid two clinical teams†[Corporate Author]
(3 results)?
Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis.
Transplantation. 2021 Nov 1;105(11):e263-e264. doi: 10.1097/TP.0000000000003908.
Transplantation. 2021.
PMID: 34310530
Free PMC article.
No abstract available.
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients.
Callaghan CJ, Mumford L, Curtis RMK, Williams SV, Whitaker H, Andrews N, Lopez Bernal J, Ushiro-Lumb I, Pettigrew GJ, Thorburn D, Forsythe JLR, Ravanan R; on behalf of the NHSBT Organ and Tissue Donation and Transplantation Clinical Team.
Callaghan CJ, et al.
Transplantation. 2022 Mar 1;106(3):436-446. doi: 10.1097/TP.0000000000004059.
Transplantation. 2022.
PMID: 34982758
Free PMC article.
BACKGROUND: The clinical effectiveness of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear. ...The risk-adjusted infection incidence rate ratio was 1 …
BACKGROUND: The clinical effectiveness of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Item in Clipboard
Cite
Cite